Correlation Between Mereo BioPharma and NextCure
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and NextCure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and NextCure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and NextCure, you can compare the effects of market volatilities on Mereo BioPharma and NextCure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of NextCure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and NextCure.
Diversification Opportunities for Mereo BioPharma and NextCure
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Mereo and NextCure is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and NextCure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCure and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with NextCure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCure has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and NextCure go up and down completely randomly.
Pair Corralation between Mereo BioPharma and NextCure
Given the investment horizon of 90 days Mereo BioPharma Group is expected to under-perform the NextCure. In addition to that, Mereo BioPharma is 1.25 times more volatile than NextCure. It trades about -0.21 of its total potential returns per unit of risk. NextCure is currently generating about -0.17 per unit of volatility. If you would invest 89.00 in NextCure on November 8, 2024 and sell it today you would lose (10.00) from holding NextCure or give up 11.24% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mereo BioPharma Group vs. NextCure
Performance |
| Timeline |
| Mereo BioPharma Group |
| NextCure |
Mereo BioPharma and NextCure Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mereo BioPharma and NextCure
The main advantage of trading using opposite Mereo BioPharma and NextCure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, NextCure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCure will offset losses from the drop in NextCure's long position.| Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
| NextCure vs. CytomX Therapeutics | NextCure vs. Spero Therapeutics | NextCure vs. Instil Bio | NextCure vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |